rituximab
not tagged
[]
ielsg37 #17icml
- large trial for pmbcl - 268 patients
- very long follow up (&gt;30 months in almost all)
- sensible approach to statistical analysis given interim analysis showed fewer events than anticipated
- response according to lugano classification 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem